U.S. Online Retail and Ecommerce Stock News

Allegiant Travel Company recently reported first-quarter 2026 results showing revenue of US$732.43 million and net income of US$42.48 million, with basic earnings per share from continuing operations of US$2.30, all higher than a year earlier despite rising fuel costs and lower system capacity. The company also delivered a record 14.9% adjusted operating margin and strong unit revenue growth while maintaining US$1.20 billions in liquidity, highlighting how its focus on peak-period flying,...

Lufax Holding (NYSE:LU) is back in focus after securities class action lawsuits followed its removal of auditor PwC. The auditor had questioned undisclosed related party transactions and prior audit opinions, putting governance and transparency under scrutiny. See our latest analysis for Lufax Holding. The recent lawsuits and auditor concerns have come after a long weak patch for investors, with a 30 day share price return of 5.91% offering only a short break. This followed a 90 day share...

In late April 2026, Benchmark Electronics reported first-quarter 2026 results showing sales of US$677.28 million and net income of US$13.02 million, while issuing second-quarter revenue guidance of US$700 million to US$740 million. The company also raised its full-year 2026 revenue growth outlook to 9%–10%, underscoring management’s confidence in momentum across medical, semiconductor capital equipment, and advanced computing and communications end markets. We’ll now consider how the...

Edesa Biotech, Inc. ( NASDAQ:EDSA ) insiders who purchased shares in the last 12 months were richly rewarded last week...

Syndax Pharmaceuticals, Inc. ( NASDAQ:SNDX ) shareholders are probably feeling a little disappointed, since its shares...

We feel now is a pretty good time to analyse AmpliTech Group, Inc.'s ( NASDAQ:AMPG ) business as it appears the company...

While L.B. Foster Company ( NASDAQ:FSTR ) shareholders have had a good week with the stock up 15%, insiders can't say...

UFP Technologies has reported its first-quarter 2026 results, with sales rising to US$154.2 million and net income edging up to US$17.5 million, alongside slightly higher basic and diluted earnings per share versus a year earlier. Beneath these headline figures, growth in medical sales, a pullback in non-medical revenue, and new Dominican Republic facilities highlight the company’s sharpening focus on MedTech and capacity to support areas such as robotic surgery and safe patient...

Commvault Systems recently reported fourth-quarter 2026 revenue of US$311.69 million and full-year revenue of US$1.18 billion, issued fiscal 2027 guidance calling for US$1.30–US$1.31 billion in total revenue, completed a major share repurchase program, and expanded its Commvault Cloud platform availability to Google Cloud Marketplace. These developments, alongside growing annual recurring revenue and upcoming presentations at Google Cloud Next 2026 and the GEOINT Symposium 2026, highlight...

Q1 earnings, guidance and BetterHelp's insurance shift Teladoc Health (TDOC) has been back in focus after Q1 2026 results and updated guidance put its BetterHelp insurance transition front and center for investors watching the virtual care stock. See our latest analysis for Teladoc Health. The stock has seen short term momentum build, with a 30 day share price return of 25.81% and a 90 day gain of 29.75%. However, the 1 year total shareholder return of 7.27% and 3 year total shareholder...

M/I Homes, Inc. reported past first-quarter 2026 results, with revenue of US$920.71 million and net income of US$67.83 million, both lower than a year earlier. The company also completed a share repurchase of 587,034 shares for US$79.65 million, reducing its share count by 2.27%, which can lift per-share metrics even as earnings soften. We’ll now examine how the weaker first-quarter earnings, alongside the ongoing buyback, affect M/I Homes’ existing investment narrative. Uncover the next big...

XCF Global, Inc. recently presented at Water Tower Research’s Circular Economy symposium and issued a Q1 2026 update outlining leadership additions, a binding offtake term sheet with BGN, and a planned June 2026 restart of its New Rise Renewables Reno facility. The company also entered a forbearance agreement with Twain and set 2027 operational targets for revenue and renewable fuel output, signaling a more defined roadmap for its Reno-based circular fuel platform. Against this backdrop,...

NASA award puts Aeluma (ALMU) quantum dot laser platform in focus A new NASA award for Aeluma (ALMU) to advance its integrated quantum dot laser platform for data communication and sensing has put the stock on the radar for investors watching AI infrastructure and defense exposure. See our latest analysis for Aeluma. Aeluma’s share price has been volatile, with a 70.83% 30 day share price return and a 44.27% 90 day share price return, while the 1 year total shareholder return sits at 107.22%,...

In April 2026, Phillips Edison & Company, Inc. raised its 2026 net income per-share guidance to US$0.79–US$0.81 and reported first-quarter revenue of US$190.74 million and net income of US$30.38 million, both higher than a year earlier. Together with Vanguard Capital Management disclosing a 5.35% ownership stake, these updates highlight growing institutional interest alongside improving profitability metrics for the grocery-anchored retail REIT. Now, we’ll consider how the upgraded full-year...

On April 28, 2026, Community Trust Bancorp’s board declared a quarterly cash dividend of US$0.53 per share, payable on July 1, 2026 to shareholders of record on June 15, 2026. The dividend decision, alongside director share awards and dividend reinvestment activity, highlights the board’s emphasis on cash returns while maintaining insider alignment. We’ll now examine how this reaffirmed quarterly dividend shapes Community Trust Bancorp’s investment narrative, particularly around income...

Why A10 Networks (ATEN) is back on investor radar A10 Networks (ATEN) just reported first quarter revenue of US$75 million and net income of US$12.03 million, ahead of the prior year, while reaffirming full year guidance that indicates earnings growth outpacing revenue growth. See our latest analysis for A10 Networks. The latest earnings beat, reiterated guidance and ongoing share buyback have landed against a strong run in the stock, with a 90 day share price return of 56.57% and a five year...

Arrowhead Pharmaceuticals (ARWR) is back in focus after Australia’s Therapeutic Goods Administration approved REDEMPLO (plozasiran) to treat adults with familial chylomicronemia syndrome, extending the drug’s reach beyond the United States, Canada, and China. See our latest analysis for Arrowhead Pharmaceuticals. Those regulatory wins appear to be reflected in the share price, with a 25.17% 1 month share price return and a 12.69% year to date share price return, alongside a 1 year total...

In April 2026, Huntington Bancshares reported first-quarter net income of US$523 million, maintained its US$0.155 quarterly common dividend, detailed a series of preferred stock dividends, and launched a new up-to-US$3.00 billion share repurchase program after completing US$250 million of an earlier buyback. The quarter highlighted how the Cadence and Veritex acquisitions drove strong revenue growth and a larger balance sheet while integration costs and higher credit provisions limited...

Daqo New Energy (DQ) just reported first quarter 2026 results that combined sharp revenue contraction, wider net losses and ongoing cash burn, while management kept a cautious tone but pointed to possible policy driven price support. See our latest analysis for Daqo New Energy. Daqo New Energy’s recent earnings and guidance arrived after a weak share price stretch, with a 90 day share price return of 14.63% and a year to date share price return of 32.74% decline, but a 1 year total...

Zymeworks (ZYME) stock is in focus after the company reported early Phase 1 data for its folate receptor alpha targeting antibody drug conjugate ZW191 at the AACR 2026 Annual Meeting. See our latest analysis for Zymeworks. At a share price of $26.78, Zymeworks has a 90 day share price return of 14.25% and a 1 year total shareholder return of 108.40%, suggesting momentum has been strengthening as data like the ZW191 Phase 1 update lands. If this kind of oncology news has your attention,...

Global markets may be dealing with inflation, shifting rate expectations, and energy volatility, but companies tackling long-term health challenges like Parkinson’s disease are still pushing ahead.

Liberty Broadband (LBRD.K) shares have been reacting to its first quarter earnings, where the company reported net income of US$203 million and earnings per share below the prior year period. See our latest analysis for Liberty Broadband. That earnings update has come alongside a sharp reset in sentiment, with a 30 day share price return of a 24.54% decline and a 1 year total shareholder return of a 55.04% loss, pointing to fading momentum rather than a short term pullback. If this kind of...

Chemed Corporation recently reported first-quarter 2026 results, with net income of US$66.3 million versus US$71.76 million a year earlier, and continued its long-running buyback by repurchasing 500,000 shares for US$197.7 million. An interesting nuance is that, despite softer earnings, Chemed has now retired about 71.73% of the shares authorized under its 2011 repurchase program, underscoring management’s ongoing commitment to returning capital. We’ll now examine how this combination of...

ASA Gold and Precious Metals (ASA) renewed its authorization to repurchase up to 5% of its common shares, highlighting management’s willingness to act when the closed end fund trades at a discount to its net asset value. See our latest analysis for ASA Gold and Precious Metals. ASA’s share price has softened in recent weeks, with a 7 day share price return of 5.37% and a 90 day share price return of 6.83%. Its 1 year total shareholder return sits at 112.77%, suggesting shorter term momentum...